Merck KGaA is seeing an uptick in demand for its lab equipment products as supply disruptions in the Middle East are causing customers to stockpile inventory.
Helene von Roeder, Merck KGaA CFO (Arne Dedert/picture-alliance/dpa/AP Images)
May 13, 2026 07:01 AM EDT
Merck KGaA's clients are stockpiling due to Iran war, supporting guidance boost
Merck KGaA appears to have a big-picture view of how the Iran war is affecting the pharma industry so far.
The German company is seeing …
Evonik on Tuesday said it is increasing its prices by 15% effective immediately for its amino and keto acid products due to…
Eastman Chemical shares will rise thanks to higher prices of several chemicals that it produces, according to the bank.
The bank upgraded the chemical manufacturer to buy from neutral.
The current conflict in the Middle East could benefit Renk's business, CEO Alexander Sagel said on an earnings call.
Concern that supply chain disruption could hit health essentials – and prices – from painkillers to cancer treatment
Bernstein called out two defense stocks that could benefit from the U.S. campaign against Iran.
